CapWealth Advisors LLC bought a new position in shares of Ingevity Corp (NYSE:NGVT) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 2,188 shares of the company’s stock, valued at approximately $223,000.

Several other large investors have also recently modified their holdings of NGVT. Greenwood Capital Associates LLC raised its position in Ingevity by 12.6% in the 2nd quarter. Greenwood Capital Associates LLC now owns 4,609 shares of the company’s stock valued at $373,000 after buying an additional 516 shares during the last quarter. State Board of Administration of Florida Retirement System raised its position in Ingevity by 2.1% in the 2nd quarter. State Board of Administration of Florida Retirement System now owns 25,772 shares of the company’s stock valued at $2,084,000 after buying an additional 530 shares during the last quarter. American International Group Inc. raised its position in Ingevity by 1.9% in the 3rd quarter. American International Group Inc. now owns 33,257 shares of the company’s stock valued at $3,388,000 after buying an additional 621 shares during the last quarter. Alps Advisors Inc. raised its position in Ingevity by 4.5% in the 2nd quarter. Alps Advisors Inc. now owns 14,729 shares of the company’s stock valued at $1,191,000 after buying an additional 629 shares during the last quarter. Finally, Metropolitan Life Insurance Co. NY raised its position in Ingevity by 5.3% in the 2nd quarter. Metropolitan Life Insurance Co. NY now owns 13,642 shares of the company’s stock valued at $1,103,000 after buying an additional 681 shares during the last quarter. 92.89% of the stock is currently owned by institutional investors.

A number of research analysts have issued reports on NGVT shares. Zacks Investment Research downgraded Ingevity from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 25th. Loop Capital set a $98.00 price objective on Ingevity and gave the company a “hold” rating in a research note on Thursday, August 16th. Oppenheimer set a $100.00 price objective on Ingevity and gave the company a “buy” rating in a research note on Wednesday, October 24th. Berenberg Bank downgraded Ingevity from a “buy” rating to a “hold” rating and set a $110.00 price objective for the company. in a research note on Tuesday, October 2nd. Finally, ValuEngine downgraded Ingevity from a “buy” rating to a “hold” rating in a research note on Tuesday, October 16th. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $104.00.

Shares of NYSE:NGVT opened at $95.02 on Thursday. The firm has a market capitalization of $4.11 billion, a price-to-earnings ratio of 36.83, a price-to-earnings-growth ratio of 2.18 and a beta of 1.48. The company has a quick ratio of 1.26, a current ratio of 2.34 and a debt-to-equity ratio of 2.31. Ingevity Corp has a 1 year low of $66.57 and a 1 year high of $106.59.

Ingevity (NYSE:NGVT) last announced its quarterly earnings data on Wednesday, October 24th. The company reported $1.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.04 by $0.12. The firm had revenue of $311.20 million during the quarter, compared to the consensus estimate of $305.50 million. Ingevity had a return on equity of 47.45% and a net margin of 15.53%. On average, equities analysts forecast that Ingevity Corp will post 3.85 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was reported by Watch List News and is the property of of Watch List News. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.watchlistnews.com/capwealth-advisors-llc-invests-223000-in-ingevity-corp-ngvt/2664168.html.

Ingevity Company Profile

Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems.

Read More: Market Capitalization

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corp (NYSE:NGVT).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.